Ray Dalio Horizon Therapeutics Public LTD CO Transaction History

Bridgewater Associates, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $650,001 - $760,064	6,567 Added 9.28%	77,311 $8.94 Million
Q2 2023 Aug 11, 2023	SELL	$96.34 - $112.38 $10.1 Million - $11.8 Million	-104,900 Reduced 59.72%	70,744 $7.28 Million
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $1.06 Million - $1.13 Million	9,913 Added 5.98%	175,644 $19.2 Million
Q4 2022 Feb 13, 2023	SELL	$62.39 - $113.8 $6.83 Million - $12.5 Million	-109,526 Reduced 39.79%	165,731 $18.9 Million
Q3 2022 Nov 10, 2022	BUY	$58.92 - $84.67 $8.46 Million - $12.2 Million	143,516 Added 108.94%	275,257 $17 Million

Q2 2022 Aug 11, 2022	BUY	$79.4 - $116.36 $9.51 Million - $13.9 Million	119,735 Added 997.29%	131,741 $10.5 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $1.04 Million - $1.32 Million	12,006 New	12,006 $1.26 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $392,761 - $477,841	-3,985 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $366,261 - $439,824	3,985 New	3,985 $437,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.